These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 18057307

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients.
    Navarro-González JF, Mora-Fernández C, Muros de Fuentes M, Donate-Correa J, Cazaña-Pérez V, García-Pérez J.
    Clin J Am Soc Nephrol; 2011 Sep; 6(9):2272-9. PubMed ID: 21784820
    [Abstract] [Full Text] [Related]

  • 25. The Phosphate Binder Ferric Citrate and Mineral Metabolism and Inflammatory Markers in Maintenance Dialysis Patients: Results From Prespecified Analyses of a Randomized Clinical Trial.
    Van Buren PN, Lewis JB, Dwyer JP, Greene T, Middleton J, Sika M, Umanath K, Abraham JD, Arfeen SS, Bowline IG, Chernin G, Fadem SZ, Goral S, Koury M, Sinsakul MV, Weiner DE, Collaborative Study Group.
    Am J Kidney Dis; 2015 Sep; 66(3):479-88. PubMed ID: 25958079
    [Abstract] [Full Text] [Related]

  • 26. Effects of phosphate on vascular function under normal conditions and influence of the uraemic state.
    Six I, Maizel J, Barreto FC, Rangrez AY, Dupont S, Slama M, Tribouilloy C, Choukroun G, Mazière JC, Bode-Boeger S, Kielstein JT, Drüeke TB, Massy ZA.
    Cardiovasc Res; 2012 Oct 01; 96(1):130-9. PubMed ID: 22822101
    [Abstract] [Full Text] [Related]

  • 27. Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?
    Oliveira RB, Cancela AL, Graciolli FG, Dos Reis LM, Draibe SA, Cuppari L, Carvalho AB, Jorgetti V, Canziani ME, Moysés RM.
    Clin J Am Soc Nephrol; 2010 Feb 01; 5(2):286-91. PubMed ID: 19965540
    [Abstract] [Full Text] [Related]

  • 28. Disturbances of Wnt/β-catenin pathway and energy metabolism in early CKD: effect of phosphate binders.
    de Oliveira RB, Graciolli FG, dos Reis LM, Cancela AL, Cuppari L, Canziani ME, Carvalho AB, Jorgetti V, Moysés RM.
    Nephrol Dial Transplant; 2013 Oct 01; 28(10):2510-7. PubMed ID: 23975746
    [Abstract] [Full Text] [Related]

  • 29. A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.
    Qunibi W, Moustafa M, Muenz LR, He DY, Kessler PD, Diaz-Buxo JA, Budoff M, CARE-2 Investigators.
    Am J Kidney Dis; 2008 Jun 01; 51(6):952-65. PubMed ID: 18423809
    [Abstract] [Full Text] [Related]

  • 30. The effects of sevelamer and calcium acetate on proxies of atherosclerotic and arteriosclerotic vascular disease in hemodialysis patients.
    Chertow GM, Raggi P, McCarthy JT, Schulman G, Silberzweig J, Kuhlik A, Goodman WG, Boulay A, Burke SK, Toto RD.
    Am J Nephrol; 2003 Jun 01; 23(5):307-14. PubMed ID: 12915774
    [Abstract] [Full Text] [Related]

  • 31. Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study.
    Chen N, Wu X, Ding X, Mei C, Fu P, Jiang G, Li X, Chen J, Liu B, La Y, Hou F, Ni Z, Fu J, Xing C, Yu X, Huang C, Zuo L, Wang L, Hunter J, Dillon M, Plone M, Neylan J.
    Nephrol Dial Transplant; 2014 Jan 01; 29(1):152-60. PubMed ID: 24151017
    [Abstract] [Full Text] [Related]

  • 32. Use of sevelamer in chronic kidney disease: beyond phosphorus control.
    Rodríguez-Osorio L, Zambrano DP, Gracia-Iguacel C, Rojas-Rivera J, Ortiz A, Egido J, González Parra E.
    Nefrologia; 2015 Jan 01; 35(2):207-17. PubMed ID: 26300515
    [Abstract] [Full Text] [Related]

  • 33. Sevelamer is cost-saving vs. calcium carbonate in non-dialysis-dependent CKD patients in italy: a patient-level cost-effectiveness analysis of the INDEPENDENT study.
    Ruggeri M, Cipriani F, Bellasi A, Russo D, Di Iorio B.
    Blood Purif; 2014 Jan 01; 37(4):316-24. PubMed ID: 25171148
    [Abstract] [Full Text] [Related]

  • 34. Mortality in kidney disease patients treated with phosphate binders: a randomized study.
    Di Iorio B, Bellasi A, Russo D, INDEPENDENT Study Investigators.
    Clin J Am Soc Nephrol; 2012 Mar 01; 7(3):487-93. PubMed ID: 22241819
    [Abstract] [Full Text] [Related]

  • 35. Calcium-containing phosphate binder use associated with accelerated atherosclerotic coronary calcification.
    Paret CL.
    J Ren Nutr; 2003 Oct 01; 13(4):288-94. PubMed ID: 14566766
    [Abstract] [Full Text] [Related]

  • 36. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients.
    Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, Ling BN, Chasan-Taber S, Dillon MA, Blair AT, Burke SK.
    Kidney Int; 2007 Nov 01; 72(9):1130-7. PubMed ID: 17728707
    [Abstract] [Full Text] [Related]

  • 37. Sevelamer hydrochloride: a review of its use for hyperphosphataemia in patients with end-stage renal disease on haemodialysis.
    Goldsmith DR, Scott LJ, Cvetković RS, Plosker GL.
    Drugs; 2008 Nov 01; 68(1):85-104. PubMed ID: 18081374
    [Abstract] [Full Text] [Related]

  • 38. [Relationship between sevelamer HCl and vascular calcification].
    Uemura K, Kakuta T, Saito A.
    Clin Calcium; 2007 Mar 01; 17(3):392-8. PubMed ID: 17339744
    [Abstract] [Full Text] [Related]

  • 39. Sevelamer and the bone-vascular axis in chronic kidney disease: bone turnover, inflammation, and calcification regulation.
    Brandenburg VM, Jahnen-Dechent W, Ketteler M.
    Kidney Int Suppl; 2009 Dec 01; (114):S26-33. PubMed ID: 19946324
    [Abstract] [Full Text] [Related]

  • 40. A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
    Prajapati VA, Galani VJ, Shah PR.
    Saudi J Kidney Dis Transpl; 2014 May 01; 25(3):530-8. PubMed ID: 24821148
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.